Veracyte, Inc. (NASDAQ: VCYT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT VERACYTE, INC.

Veracyte, Inc. (NASDAQ: VCYT)
Listen to this Section


$48.74
+0.0100 ( +0.02% ) 0.6K

Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.

Market Data


Open $48.74
Previous Close $48.73
Volume 0.6K
Market Cap $3.89B
Day Range $47.06 - $50.50
52 Week Range $22.61 - $50.71
Shares Outstanding 79.79M
Change % +0.02%
Net Change ▲ 0.0100
Insider Ownership -0.02%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2013
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -49,809.00

Date Type Amount Purchased Purchaser
2024-08-14 Sale -99.00 JONES EVAN/ FA
2024-08-13 Sale -300.00 JONES EVAN/ FA
2024-08-09 Sale -2500.00 Holstein Jens
2024-08-09 Sale -1214.00 JONES EVAN/ FA
2024-07-18 Sale -7500.00 EASTHAM KARIN
2024-07-18 Sale -1277.00 Leite John
2024-07-18 Sale -2500.00 Holstein Jens
2024-06-17 Sale -11473.00 JONES EVAN/ FA
2024-06-17 Sale -11473.00 Barr Eliav
2024-06-17 Sale -11473.00 Holstein Jens

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 12, 2025
4 Insider transactions 1 Nov 07, 2025
4 Insider transactions 1 Nov 07, 2025
4 Insider transactions 1 Nov 07, 2025
4 Insider transactions 1 Nov 07, 2025
10-q Quarterly Reports 66 Nov 05, 2025
8-k 8K-related 14 Nov 04, 2025
4 Insider transactions 1 Oct 30, 2025
4 Insider transactions 1 Oct 07, 2025
4 Insider transactions 1 Oct 03, 2025

Latest News


× Before browsing our site, please accept our cookies policy